Selected research
Industry Growth & Trends
Global Parathyroid Hormone Industry Growth and Trends Forecast to 2032
Market perspective
The global Parathyroid Hormone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parathyroid Hormone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Parathyroid Hormone include Sanofi SA, Merck, Eli Lilly, Pfizer, GlaxoSmithKline Plc, Paladin Labs Inc, OSI Pharmaceuticals, Natpara and Cell Genesys Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Parathyroid Hormone market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Parathyroid Hormone market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parathyroid Hormone market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parathyroid Hormone.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Parathyroid Hormone market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Parathyroid Hormone Market by Company
Sanofi SA
Merck
Eli Lilly
Pfizer
GlaxoSmithKline Plc
Paladin Labs Inc
OSI Pharmaceuticals
Natpara
Cell Genesys Inc
ALZA Corporation
Abbott Laboratories
Parathyroid Hormone Segment by Type
Hypocalcemia
Hypoparathyroidism
Parathyroid Hormone Segment by Application
Hospitals
Clinics
Other
Parathyroid Hormone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parathyroid Hormone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parathyroid Hormone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parathyroid Hormone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parathyroid Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Parathyroid Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hypocalcemia
- Hypoparathyroidism
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Sanofi SA
- Merck
- Eli Lilly
- Pfizer
- GlaxoSmithKline Plc
- Paladin Labs Inc
- OSI Pharmaceuticals
- Natpara
- Cell Genesys Inc
- ALZA Corporation
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Parathyroid Hormone Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Parathyroid Hormone Sales Estimates and Forecasts (2021-2032)
- 1.3 Parathyroid Hormone Market by Type
- 1.3.1 Hypocalcemia
- 1.3.2 Hypoparathyroidism
- 1.4 Global Parathyroid Hormone Market Size by Type
- 1.4.1 Global Parathyroid Hormone Market Size Overview by Type (2021-2032)
- 1.4.2 Global Parathyroid Hormone Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Parathyroid Hormone Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Parathyroid Hormone Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Parathyroid Hormone Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Parathyroid Hormone Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Parathyroid Hormone Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Parathyroid Hormone Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Parathyroid Hormone Industry Trends
- 2.2 Parathyroid Hormone Industry Drivers
- 2.3 Parathyroid Hormone Industry Opportunities and Challenges
- 2.4 Parathyroid Hormone Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Parathyroid Hormone Revenue (2021-2026)
- 3.2 Global Top Players by Parathyroid Hormone Sales (2021-2026)
- 3.3 Global Top Players by Parathyroid Hormone Price (2021-2026)
- 3.4 Global Parathyroid Hormone Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parathyroid Hormone Major Company Production Sites & Headquarters
- 3.6 Global Parathyroid Hormone Company, Product Type & Application
- 3.7 Global Parathyroid Hormone Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Parathyroid Hormone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Parathyroid Hormone Players Market Share by Revenue in 2025
- 3.8.3 2025 Parathyroid Hormone Tier 1, Tier 2, and Tier 3
4 Parathyroid Hormone Regional Status and Outlook
- 4.1 Global Parathyroid Hormone Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Parathyroid Hormone Historic Market Size by Region
- 4.2.1 Global Parathyroid Hormone Sales in Volume by Region (2021-2026)
- 4.2.2 Global Parathyroid Hormone Sales in Value by Region (2021-2026)
- 4.2.3 Global Parathyroid Hormone Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Parathyroid Hormone Forecasted Market Size by Region
- 4.3.1 Global Parathyroid Hormone Sales in Volume by Region (2027-2032)
- 4.3.2 Global Parathyroid Hormone Sales in Value by Region (2027-2032)
- 4.3.3 Global Parathyroid Hormone Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Parathyroid Hormone by Application
- 5.1 Parathyroid Hormone Market by Application
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Other
- 5.2 Global Parathyroid Hormone Market Size by Application
- 5.2.1 Global Parathyroid Hormone Market Size Overview by Application (2021-2032)
- 5.2.2 Global Parathyroid Hormone Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Parathyroid Hormone Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Parathyroid Hormone Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Parathyroid Hormone Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Parathyroid Hormone Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Parathyroid Hormone Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Parathyroid Hormone Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi SA
- 6.1.1 Sanofi SA Company Information
- 6.1.2 Sanofi SA Business Overview
- 6.1.3 Sanofi SA Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi SA Parathyroid Hormone Product Portfolio
- 6.1.5 Sanofi SA Recent Developments
- 6.2 Merck
- 6.2.1 Merck Company Information
- 6.2.2 Merck Business Overview
- 6.2.3 Merck Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Parathyroid Hormone Product Portfolio
- 6.2.5 Merck Recent Developments
- 6.3 Eli Lilly
- 6.3.1 Eli Lilly Company Information
- 6.3.2 Eli Lilly Business Overview
- 6.3.3 Eli Lilly Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Eli Lilly Parathyroid Hormone Product Portfolio
- 6.3.5 Eli Lilly Recent Developments
- 6.4 Pfizer
- 6.4.1 Pfizer Company Information
- 6.4.2 Pfizer Business Overview
- 6.4.3 Pfizer Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pfizer Parathyroid Hormone Product Portfolio
- 6.4.5 Pfizer Recent Developments
- 6.5 GlaxoSmithKline Plc
- 6.5.1 GlaxoSmithKline Plc Company Information
- 6.5.2 GlaxoSmithKline Plc Business Overview
- 6.5.3 GlaxoSmithKline Plc Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 GlaxoSmithKline Plc Parathyroid Hormone Product Portfolio
- 6.5.5 GlaxoSmithKline Plc Recent Developments
- 6.6 Paladin Labs Inc
- 6.6.1 Paladin Labs Inc Company Information
- 6.6.2 Paladin Labs Inc Business Overview
- 6.6.3 Paladin Labs Inc Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Paladin Labs Inc Parathyroid Hormone Product Portfolio
- 6.6.5 Paladin Labs Inc Recent Developments
- 6.7 OSI Pharmaceuticals
- 6.7.1 OSI Pharmaceuticals Company Information
- 6.7.2 OSI Pharmaceuticals Business Overview
- 6.7.3 OSI Pharmaceuticals Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 OSI Pharmaceuticals Parathyroid Hormone Product Portfolio
- 6.7.5 OSI Pharmaceuticals Recent Developments
- 6.8 Natpara
- 6.8.1 Natpara Company Information
- 6.8.2 Natpara Business Overview
- 6.8.3 Natpara Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Natpara Parathyroid Hormone Product Portfolio
- 6.8.5 Natpara Recent Developments
- 6.9 Cell Genesys Inc
- 6.9.1 Cell Genesys Inc Company Information
- 6.9.2 Cell Genesys Inc Business Overview
- 6.9.3 Cell Genesys Inc Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Cell Genesys Inc Parathyroid Hormone Product Portfolio
- 6.9.5 Cell Genesys Inc Recent Developments
- 6.10 ALZA Corporation
- 6.10.1 ALZA Corporation Company Information
- 6.10.2 ALZA Corporation Business Overview
- 6.10.3 ALZA Corporation Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 ALZA Corporation Parathyroid Hormone Product Portfolio
- 6.10.5 ALZA Corporation Recent Developments
- 6.11 Abbott Laboratories
- 6.11.1 Abbott Laboratories Company Information
- 6.11.2 Abbott Laboratories Business Overview
- 6.11.3 Abbott Laboratories Parathyroid Hormone Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Abbott Laboratories Parathyroid Hormone Product Portfolio
- 6.11.5 Abbott Laboratories Recent Developments
7 North America by Country
- 7.1 North America Parathyroid Hormone Sales by Country
- 7.1.1 North America Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Parathyroid Hormone Sales by Country (2021-2026)
- 7.1.3 North America Parathyroid Hormone Sales Forecast by Country (2027-2032)
- 7.2 North America Parathyroid Hormone Market Size by Country
- 7.2.1 North America Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Parathyroid Hormone Market Size by Country (2021-2026)
- 7.2.3 North America Parathyroid Hormone Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Parathyroid Hormone Sales by Country
- 8.1.1 Europe Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Parathyroid Hormone Sales by Country (2021-2026)
- 8.1.3 Europe Parathyroid Hormone Sales Forecast by Country (2027-2032)
- 8.2 Europe Parathyroid Hormone Market Size by Country
- 8.2.1 Europe Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Parathyroid Hormone Market Size by Country (2021-2026)
- 8.2.3 Europe Parathyroid Hormone Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Parathyroid Hormone Sales by Country
- 9.1.1 Asia-Pacific Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Parathyroid Hormone Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Parathyroid Hormone Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Parathyroid Hormone Market Size by Country
- 9.2.1 Asia-Pacific Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Parathyroid Hormone Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Parathyroid Hormone Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Parathyroid Hormone Sales by Country
- 10.1.1 South America Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Parathyroid Hormone Sales by Country (2021-2026)
- 10.1.3 South America Parathyroid Hormone Sales Forecast by Country (2027-2032)
- 10.2 South America Parathyroid Hormone Market Size by Country
- 10.2.1 South America Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Parathyroid Hormone Market Size by Country (2021-2026)
- 10.2.3 South America Parathyroid Hormone Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Parathyroid Hormone Sales by Country
- 11.1.1 Middle East and Africa Parathyroid Hormone Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Parathyroid Hormone Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Parathyroid Hormone Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Parathyroid Hormone Market Size by Country
- 11.2.1 Middle East and Africa Parathyroid Hormone Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Parathyroid Hormone Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Parathyroid Hormone Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Parathyroid Hormone Value Chain Analysis
- 12.1.1 Parathyroid Hormone Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Parathyroid Hormone Production Mode & Process
- 12.2 Parathyroid Hormone Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Parathyroid Hormone Distributors
- 12.2.3 Parathyroid Hormone Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst